The Impact of Monopoly on the Pharmaceutical Market
DOI:
https://doi.org/10.52340/splogos.2025.03.24Keywords:
Competition, Medicines, Monopoly, Pharmaceutical market, Monopoly structureAbstract
The presence of monopolistic structures in the pharmaceutical market poses significant challenges to equitable access, affordability, and innovation. This study explores the current landscape of pharmaceutical monopolies, their impact on medicine pricing and availability, and the effectiveness of national and international regulatory responses. The primary aim is to analyze how competition-enhancing policies can mitigate monopolistic practices and promote fair market conditions. Using a qualitative methodology based on comparative policy analysis and case studies from countries such as the United States, European Union member states, Japan, and developing economies, the paper evaluates strategies like generic medicine promotion, market entry facilitation, and antitrust regulations. The findings highlight that well-designed regulatory frameworks, combined with technological innovation and consumer empowerment, significantly contribute to reducing monopolistic influence and improving access to essential medicines. The study concludes that a sustainable and fair pharmaceutical market requires transparent, adaptive, and collaborative policy approaches that balance innovation with competition, ultimately supporting the resilience of healthcare systems and improving public health outcomes.
Downloads
References
Carrier, Michael A., and Felipe Araya. "Pharmaceutical Antitrust Enforcement in the United States and Chile." Journal of Law and the Biosciences 8, no. 1 (2021): lsab013. https://doi.org/10.1093/jlb/lsab013.
Colangelo, Mario. Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study. Oxford: Hart Publishing, 2023. https://doi.org/10.5040/9781509965540.
Competition Commission of India. Report on Pharmaceutical Sector Competition. 2023. https://www.cci.gov.in/reports/pharma-sector-competition.
Crane, Christina R. "Monopoly Medicine: A Regulatory Cure for the Pharmaceutical Industry's Anticompetitive Conduct." Loyola of Los Angeles Law Review 50, no. 4 (2017): 831–868. https://digitalcommons.lmu.edu/llr/vol50/iss4/2.
Dosi, Giovanni, Luigi Marengo, Jacopo Staccioli, and Maria Enrica Virgillito. "Big Pharma and Monopoly Capitalism: A Long-Term View." Structural Change and Economic Dynamics 65 (2023): 15–35. https://doi.org/10.1016/j.strueco.2023.01.004.
European Commission. Pharmaceutical Strategy for Europe. January 15, 2023. https://ec.europa.eu/health/pharmaceutical-strategy_en.
Federal Trade Commission. Pharmaceutical Antitrust Enforcement. November 10, 2023. https://www.ftc.gov/news-events/topics/health-care/pharmaceutical-antitrust.
Pharmaceuticals and Medical Devices Agency. Regulatory Framework of Pharmaceuticals in Japan. 2022. https://www.pmda.go.jp/english/regulatory-framework.html.
Shashiashvili, Nana, and Nino Bakradze. "Pharmaceutical Market & Pharmacy Services: Analysis of Challenges and Opportunities on the Example of the German Model." Georgian Scientists 7, no. 2 (2025): 211–225. https://doi.org/10.52340/gs.2025.07.02.08.
Shashiashvili, Nana, Natia Kvizhinadze, and Nino Bakradze. "Analysis of Global Policies on Generic Medicines." Economics 107, nos. 3–5 (2025): 53–59. https://doi.org/10.36962/ECS107/3-5/2025-53.
Shashiashvili, Nana, Natia Kvizhinadze, and Nino Bakradze. "Regulation of Pharmacy Business Ownership: International Case Studies." Experimental and Clinical Medicine Georgia, no. 2 (2025): 28–31. https://doi.org/10.52340/jecm.2025.02.06.
Shashiashvili, Nana. "Regulating Pharmaceutical Business Integration – Regulatory Frameworks and Impact on the Healthcare System." Experimental and Clinical Medicine Georgia, no. 2 (2025): 23–27. https://doi.org/10.52340/jecm.2025.02.05.
U.S. Food and Drug Administration. Generic Drug Competition and Pricing. March 2, 2024. https://www.fda.gov/drugs/generic-drug-competition-pricing.
Weng, Jing, and Na Liu. "Different Routes the Same Destination: A Comparative Study of Antitrust Regulation for Pharmaceutical Industry in the United States and China." Frontiers in Pharmacology 16 (2025): 1557876. https://doi.org/10.3389/fphar.2025.1557876.
World Trade Organization. TRIPS Agreement and Intellectual Property Rights. July 5, 2021. https://www.wto.org/english/tratop_e/trips_e/intel2_e.htm.
Xu, Changchang, and Dongmei Zhu. "On Conflicts between Pharmaceutical Patent Protection and the Right to Life and Health Based on a Stackelberg Game." International Journal of Environmental Research and Public Health 18, no. 3 (2021): 1119. https://doi.org/10.3390/ijerph18031119.
